Homeostasis, injury and recovery dynamics at multiple scales in a self-organizing mouse intestinal crypt

  1. Louis Gall
  2. Carrie Duckworth
  3. Ferran Jardi
  4. Lieve Lammens
  5. Aimee Parker
  6. Ambra Bianco
  7. Holly Kimko
  8. David Mark Pritchard
  9. Carmen Pin  Is a corresponding author
  1. AstraZeneca, United Kingdom
  2. University of Liverpool, United Kingdom
  3. Janssen, Belgium
  4. Quadram Institute, United Kingdom

Abstract

The maintenance of the functional integrity of the intestinal epithelium requires a tight coordination between cell production, migration and shedding along the crypt-villus axis. Dysregulation of these processes may result in loss of the intestinal barrier and disease. With the aim of generating a more complete and integrated understanding of how the epithelium maintains homeostasis and recovers after injury, we have built a multi-scale agent-based model (ABM) of the mouse intestinal epithelium. We demonstrate that stable, self-organizing behaviour in the crypt emerges from the dynamic interaction of multiple signalling pathways, such as Wnt, Notch, BMP, ZNRF3/RNF43 and YAP-Hippo pathways, which regulate proliferation and differentiation, respond to environmental mechanical cues, form feedback mechanisms and modulate the dynamics of the cell cycle protein network. The model recapitulates the crypt phenotype reported after persistent stem cell ablation and after the inhibition of the CDK1 cycle protein. Moreover, we simulated 5-fluorouracil (5-FU)-induced toxicity at multiple scales starting from DNA and RNA damage, which disrupts the cell cycle, cell signalling, proliferation, differentiation and migration and leads to loss of barrier integrity. During recovery, our in-silico crypt regenerates its structure in a self-organizing, dynamic fashion driven by dedifferentiation and enhanced by negative feedback loops. Thus, the model enables the simulation of xenobiotic-, in particular chemotherapy-, induced mechanisms of intestinal toxicity and epithelial recovery. Overall, we present a systems model able to simulate the disruption of molecular events and its impact across multiple levels of epithelial organization and demonstrate its application to epithelial research and drug development.

Data availability

The current manuscript is a computational study. No data have been generated for this manuscript. Modelling code is uploaded as Source Code.zip file

Article and author information

Author details

  1. Louis Gall

    Clinical and Quantitative Pharmacology, AstraZeneca, Cambridge, United Kingdom
    Competing interests
    Louis Gall, Employee and shareholder of AstraZeneca Plc.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-1805-2357
  2. Carrie Duckworth

    Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, United Kingdom
    Competing interests
    No competing interests declared.
  3. Ferran Jardi

    Preclinical Sciences and Translational Safety, Janssen, Beerse, Belgium
    Competing interests
    Ferran Jardi, Employee of Johnson & Johnson..
  4. Lieve Lammens

    Preclinical Sciences and Translational Safety, Janssen, Beerse, Belgium
    Competing interests
    Lieve Lammens, Employee and shareholder of Johnson & Johnson..
  5. Aimee Parker

    Gut Microbes and Health Programme, Quadram Institute, Norwich, United Kingdom
    Competing interests
    No competing interests declared.
  6. Ambra Bianco

    Clinical Pharmacology and Safety Sciences, AstraZeneca, Cambridge, United Kingdom
    Competing interests
    Ambra Bianco, Employee and shareholder of AstraZeneca Plc.
  7. Holly Kimko

    Clinical and Quantitative Pharmacology, AstraZeneca, Cambridge, United Kingdom
    Competing interests
    Holly Kimko, Employee and shareholder of AstraZeneca Plc.
  8. David Mark Pritchard

    Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, United Kingdom
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-7971-3561
  9. Carmen Pin

    Clinical and Quantitative Pharmacology, AstraZeneca, Cambridge, United Kingdom
    For correspondence
    carmen.pin@astrazeneca.com
    Competing interests
    Carmen Pin, Employee and shareholder of AstraZeneca Plc.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8734-6167

Funding

European Federation of Pharmaceutical Industries and Associations (Innovative Medicines Initiative 2,No. 116030)

  • Louis Gall
  • Carrie Duckworth
  • Ferran Jardi
  • Lieve Lammens
  • David Mark Pritchard
  • Carmen Pin

Horizon 2020 Framework Programme (Innovative Medicines Initiative 2,No. 116030)

  • Louis Gall
  • Carrie Duckworth
  • Ferran Jardi
  • Lieve Lammens
  • David Mark Pritchard
  • Carmen Pin

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All experiments were performed in an Association for Assessment and Accreditation of Laboratory Animal Care approved rodent facility and in accordance with the applicable animal welfare guidelines and legislation. Experimental procedures were approved by the institutional ethics committee. Ten-week-old male C57/BL6Y mice were obtained from Charles River (France). Mice were housed in polysulfon cages with corncob bedding under standard conditions of room temperature (21{degree sign}C {plus minus} 2), relative humidity (55% {plus minus} 15) and a 12-h light cycle. Water and a certified rodent pelleted maintenance diet were supplied ad libitum. Nest material and rodent retreats were provided for environmental enrichment.

Copyright

© 2023, Gall et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,229
    views
  • 193
    downloads
  • 1
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Louis Gall
  2. Carrie Duckworth
  3. Ferran Jardi
  4. Lieve Lammens
  5. Aimee Parker
  6. Ambra Bianco
  7. Holly Kimko
  8. David Mark Pritchard
  9. Carmen Pin
(2023)
Homeostasis, injury and recovery dynamics at multiple scales in a self-organizing mouse intestinal crypt
eLife 12:e85478.
https://doi.org/10.7554/eLife.85478

Share this article

https://doi.org/10.7554/eLife.85478

Further reading

    1. Computational and Systems Biology
    2. Genetics and Genomics
    Jia-Ying Su, Yun-Lin Wang ... Chien-Ling Lin
    Research Article

    Untranslated regions (UTRs) contain crucial regulatory elements for RNA stability, translation and localization, so their integrity is indispensable for gene expression. Approximately 3.7% of genetic variants associated with diseases occur in UTRs, yet a comprehensive understanding of UTR variant functions remains limited due to inefficient experimental and computational assessment methods. To systematically evaluate the effects of UTR variants on RNA stability, we established a massively parallel reporter assay on 6555 UTR variants reported in human disease databases. We examined the RNA degradation patterns mediated by the UTR library in two cell lines, and then applied LASSO regression to model the influential regulators of RNA stability. We found that UA dinucleotides and UA-rich motifs are the most prominent destabilizing element. Gain of UA dinucleotide outlined mutant UTRs with reduced stability. Studies on endogenous transcripts indicate that high UA-dinucleotide ratios in UTRs promote RNA degradation. Conversely, elevated GC content and protein binding on UA dinucleotides protect high-UA RNA from degradation. Further analysis reveals polarized roles of UA-dinucleotide-binding proteins in RNA protection and degradation. Furthermore, the UA-dinucleotide ratio of both UTRs is a common characteristic of genes in innate immune response pathways, implying a coordinated stability regulation through UTRs at the transcriptomic level. We also demonstrate that stability-altering UTRs are associated with changes in biobank-based health indices, underscoring the importance of precise UTR regulation for wellness. Our study highlights the importance of RNA stability regulation through UTR primary sequences, paving the way for further exploration of their implications in gene networks and precision medicine.

    1. Computational and Systems Biology
    2. Medicine
    Hong Yang, Cheng Zhang ... Adil Mardinoglu
    Research Article

    Excessive consumption of sucrose, in the form of sugar-sweetened beverages, has been implicated in the pathogenesis of metabolic dysfunction‐associated fatty liver disease (MAFLD) and other related metabolic syndromes. The c-Jun N-terminal kinase (JNK) pathway plays a crucial role in response to dietary stressors, and it was demonstrated that the inhibition of the JNK pathway could potentially be used in the treatment of MAFLD. However, the intricate mechanisms underlying these interventions remain incompletely understood given their multifaceted effects across multiple tissues. In this study, we challenged rats with sucrose-sweetened water and investigated the potential effects of JNK inhibition by employing network analysis based on the transcriptome profiling obtained from hepatic and extrahepatic tissues, including visceral white adipose tissue, skeletal muscle, and brain. Our data demonstrate that JNK inhibition by JNK-IN-5A effectively reduces the circulating triglyceride accumulation and inflammation in rats subjected to sucrose consumption. Coexpression analysis and genome-scale metabolic modeling reveal that sucrose overconsumption primarily induces transcriptional dysfunction related to fatty acid and oxidative metabolism in the liver and adipose tissues, which are largely rectified after JNK inhibition at a clinically relevant dose. Skeletal muscle exhibited minimal transcriptional changes to sucrose overconsumption but underwent substantial metabolic adaptation following the JNK inhibition. Overall, our data provides novel insights into the molecular basis by which JNK inhibition exerts its metabolic effect in the metabolically active tissues. Furthermore, our findings underpin the critical role of extrahepatic metabolism in the development of diet-induced steatosis, offering valuable guidance for future studies focused on JNK-targeting for effective treatment of MAFLD.